RDNT · NASDAQ · Medical - Diagnostics & Research

RadNet (RDNT)

Operates outpatient imaging centers and sells DeepHealth radiology software and clinical AI.

$74.13
vs last close+1.46 (+2.00%)
Loading prices…

RadNet, Inc.RDNT
Health Care

Operates fixed-site outpatient imaging centers that earn fees for MRI, CT, PET, mammography and other scans, while DeepHealth sells radiology software, remote-scanning tools and clinical AI. Revenue remains dominated by the U.S. center network and depends on physician referrals and third-party reimbursement.

Runs the Imaging Centers segment, a U.S. network of 442 fixed-site outpatient centers offering MRI, CT, PET, mammography, ultrasound, X-ray, nuclear medicine and fluoroscopy. Builds density in regional markets through acquisitions, new sites and health-system joint ventures; multimodality locations broaden referral coverage and improve equipment use. Scan volume and service mix drive revenue, with advanced imaging generally carrying higher margins than routine exams.

Sells Digital Health products under DeepHealth, including RIS/PACS, DeepHealth OS, clinical AI, reporting and remote-scanning tools, to its own network and outside hospitals, health systems and imaging providers worldwide. The segment expanded into routine and acute-care imaging through Gleamer. Operations depend on physician referrals, commercial and government reimbursement, qualified radiologists and technologists, and continuing investment in imaging equipment and regulated clinical software.

Company facts

CEOHoward G. Berger
ListedJan 3, 1997
ExchangeNASDAQ
HeadquartersLos Angeles, CA
CountryUnited States
Employees11,264
CIK0000790526
ISINUS7504911022

Market cap$5.71B
EPS (ttm)−$0.2678
P/E (ttm)−271.36
ROE-2.0%
P/B5.21
P/S2.52
Dividend yieldDiv yield
Beta1.02vs XLV 0.67

Price target$65.00−10.6%Average of 11 analysts
ConsensusBuy9 of 11 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
May 20, 2026BarclaysReiterate
Rating: Target: $79
Rating: OverweightTarget: $65
Mar 3, 2026JefferiesTarget
Target: $100
Target: $91
Jan 9, 2026UBSTarget
Target:
Target: $92
Jan 8, 2026KeyBancTarget
Target:
Target: $92
Dec 17, 2025Truist FinancialTarget
Target: $81
Target: $90

Next report
Nov 9, 26
in 48 days
EPS estimate
$0.21
Revenue estimate
$640.0M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.07−$0.50$0.31$0.20$0.23−$0.28$0.29Pending
Estimate$0.15−$0.17$0.17$0.22$0.19−$0.14$0.20$0.21
Surprise−51.6%−194.1%+82.4%−10.3%+21.1%−100.0%+44.0%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$477.1M$471.4M$498.2M$522.9M$547.7M$575.6M$622.7MPending
Estimate$461.8M$443.1M$489.0M$494.5M$516.7M$557.9M$610.9M$640.0M
Surprise+3.3%+6.4%+1.9%+5.7%+6.0%+3.2%+1.9%
Estimate$0.21
ReportedDue Nov 9, 2026
Estimate$640.0M
ReportedDue Nov 9, 2026
View details

Debt to equity199.10%
Current ratio148.40%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$461.1M$477.1M$471.4M$498.2M$522.9M$547.7M$575.6M$622.7M
Net income$3.2M$5.3M−$37.9M$14.5M$5.4M−$597.0K−$33.5M$7.5M
Net margin0.7%1.1%0.0%2.9%1.0%0.0%0.0%1.2%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$33.9M$24.5M−$24.1M$30.9M$32.7M$35.1M−$16.4M$39.5M
YoY growth−21.6%+0.8%Turned loss−11.4%−3.6%+43.0%Loss narrowed+27.8%

Balance sheet, Jun 30, 2026Cash & short-term investments $726.3M · Total debt $2.18B · Total assets $4.23B · Shareholders' equity $1.10B

Revenue
$622.7M
Operating income
$39.5M
Net income
$7.5M
View details

No dividends on record.

Institutions104.41%82.17M shares
336 holders · as of Jun 30, 2026
Insiders3.00%2.36M shares
13 holders · as of Jun 22, 2026
Adds to107.41%

78.70M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 107.41%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
13.92%10.96Mas of Jun 30, 2026
RTW Investments, LPInstitution
6.16%4.85Mas of Jun 30, 2026
Price T Rowe Associates Inc /MD/Institution
5.72%4.50Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
5.17%4.07Mas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
4.06%3.19Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Jun 18, 2026David L. Swartzdirector−2,699$53.89
Jun 16, 2026Cornelis Wesdorpofficer: Pres & CEO, Digital Health−4,750$58.11
Jun 15, 2026Stephen M. Forthuberofficer: Pres & CEO-Eastern Operations−44,067$58.16
Mar 19, 2026Alma Gregory Sorensendirector, officer: Chief Strategy Officer−15,000$62.20
Mar 18, 2026Alma Gregory Sorensendirector, officer: Chief Strategy Officer−15,000$62.15
View details

  • GE HealthCare

    Imaging hardware giant with 115 FDA-cleared AI algorithms across modalities

  • HCA Healthcare

    Largest US hospital; hospital-owned outpatient imaging competes for volume

  • Philips (ADR)

    Dutch health-tech giant; IntelliSpace AI informatics competes with DeepHealth OS

Compare

CompanyPriceChange
RadNet$74.13+2.00%$5.71B130.52.5+25.0%
GE HealthCare$66.50+2.61%$29.27B18.812.81.4+5.8%
HCA Healthcare$434.07+1.90%$92.22B14.314.21.2+8.7%
Philips (ADR)$24.97+0.26%$24.34B18.713.01.2−2.8%
Median18.713.01.2+5.8%